Biological Prognostic Markers in Chronic Lymphocytic Leukemia

by Vladimíra Vroblová, Lukáš Smolej, Filip Vrbacký, Karolína Jankovičová, Monika Hrudková, Jaroslav Malý, Jan Krejsek
Published 2009-01-01

Addition of Rituximab Significantly Improves Outcomes in Patients with Diffuse Large B-cell Lymphoma – a Single-center, Retrospective Study

by David Belada, Lukáš Smolej, Monika Hrudková, Pavla Štěpánková, Alice Sýkorová, Pavel Žák, Jiří Bukač, Jaroslav Malý
Published 2007-01-01